New York City, NY – According to filings with the U.S. Securities and Exchange Commission, H1 Insights is raising $58,023,533.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ariel Katz played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About H1 Insights

H1 is the first company to arm healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases. The company provides real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, helping companies make smarter scientific decisions. Working with medical affairs and strategy teams who span all phases of the development lifecycle, H1 provides the complete picture of institutions, experts, scholarly content, markets, competitors and new opportunities through research grounded in actual data and clinical findings.

To learn more about H1 Insights, visit http://www.h1insights.com/

Contact:
Ariel Katz, Chief Executive Officer
646-363-6450
https://www.linkedin.com/in/arielbkatz/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved